$HQL insiders have traded $HQL stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales. Here’s a ...
HQL focuses on the life sciences industry with a 74% allocation to biotechnology stocks. It pays a 2% quarterly managed distribution. The boom-bust nature of biotech stocks may not be suitable for a ...
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, ...
abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL’s income-focused strategy relies on net realized gains, supporting ...
Get complete details on the Abrdn Life Sciences Investors stock dividend, including HQL dividend history and HQL dividend yield. Find the latest HQL dividend date, ex-dividend date, and dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results